Delivery of Soluble Ferric Pyrophosphate (SFP) Via the Dialysate to Maintain Iron Balance in Hemodialysis Patients

NCT00604565 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped major planned changes to study design

Conditions

End Stage Renal Disease (ESRD)

Interventions

DRUG: soluble ferric pyrophosphate (SFP)
OTHER: placebo

Sponsor

Charles Drew University of Medicine and Science

Collaborators

[object Object]
[object Object]